Connecting Care: A Multidisciplinary Panel Discussion on the Use of Neutralizing Monoclonal Antibodies in Ambulatory Patients With COVID-19

Published: Feb. 19, 2021, 6 a.m.

Host: Mimi Secor, DNP, FNP-BC, FAANP
Guest: Karen Bloch, MD, MPH, FIDSA, FACP
Guest: Jarrod W. Kile, RPh, BCPS

Hear from a multidisciplinary, interprofessional panel of experts on COVID-19 infusion therapies with virus-neutralizing monoclonal antibodies (mAbs). This activity features a clinical discussion of the Emergency Use Authorization criteria and data from real-world use of mAbs in ambulatory patients. Learn how this treatment reduces the chance of patients with COVID-19 developing severe illness and what could be done to effectively implement the outpatient delivery of mAbs to patients with COVID-19 in your practice.